Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Corticotropin-independent Cushing's syndrome is caused by tumors or hyperplasia of the adrenal cortex. The molecular pathogenesis of cortisol-producing adrenal adenomas is not well understood. METHODS: We performed exome sequencing of tumor-tissue specimens from 10 patients with cortisol-producing adrenal adenomas and evaluated recurrent mutations in candidate genes in an additional 171 patients with adrenocortical tumors. We also performed genomewide copy-number analysis in 35 patients with cortisol-secreting bilateral adrenal hyperplasias. We studied the effects of these genetic defects both clinically and in vitro. RESULTS: Exome sequencing revealed somatic mutations in PRKACA, which encodes the catalytic subunit of cyclic AMP-dependent protein kinase (protein kinase A [PKA]), in 8 of 10 adenomas (c.617A→C in 7 and c.595_596insCAC in 1). Overall, PRKACA somatic mutations were identified in 22 of 59 unilateral adenomas (37%) from patients with overt Cushing's syndrome; these mutations were not detectable in 40 patients with subclinical hypercortisolism or in 82 patients with other adrenal tumors. Among 35 patients with cortisol-producing hyperplasias, 5 (including 2 first-degree relatives) carried a germline copy-number gain (duplication) of the genomic region on chromosome 19 that includes PRKACA. In vitro studies showed impaired inhibition of both PKA catalytic subunit mutants by the PKA regulatory subunit, whereas cells from patients with germline chromosomal gains showed increased protein levels of the PKA catalytic subunit; in both instances, basal PKA activity was increased. CONCLUSIONS: Genetic alterations of the catalytic subunit of PKA were found to be associated with human disease. Germline duplications of this gene resulted in bilateral adrenal hyperplasias, whereas somatic PRKACA mutations resulted in unilateral cortisol-producing adrenal adenomas. (Funded by the European Commission Seventh Framework Program and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Somatic activating mutations of protein kinase A catalytic subunit (PRKACA) has been implicated in up to 50% of patients with adenomas with clinical Cushing’s syndrome, but not in adenomas producing less cortisol (138,142,147).”
From Adrenal incidentaloma (2020) · cites this paper as [147]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these mutations, the most frequently found (PKA-CL205R) is a point mutation leading to substitution of Leu at position 205 (or 206, depending on the convention used for numbering) with Arg and has been found in up to 67% of Cushing’s syndrome patients (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The L205R mutation was discovered independently in our laboratory and in other laboratories as the dominant genetic alteration in cortisol-producing adrenocortical adenomas responsible for Cushing’s syndrome (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Later on, our group and others discovered single mutations or insertions at the R/C interface that are linked to adrenal Cushing’s syndrome (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As expected, the 60-minute post-ACTH cortisol was higher than the 30-minute cortisol on each of the cortisol assays evaluated [26, 28, 38].”
From New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays (2021) · cites this paper as [38]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationNewell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153
Self-citationManagement of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945 · cited 1×
“Adrenal adenomas are common, with a prevalence of at least 3% among persons older than 50 years of age.(3) Whereas only a subset of these tumors is associated with overt Cushing’s syndrome, some degree of cortisol excess is present, depending on the diagnostic criteria applied,(4) in up to 47% of patients with adrenal…”
BackgroundThe clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt-Rasmussen, U., Hagen, C., Jørgensen, J., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 619
Beuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577
Self-citationPersistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors
Calebiro, D., Nikolaev, V. O., Gagliani, M. C., de Filippis, T., Dees, C., Tacchetti, C., Persani, L., & Lohse, M. J. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000172 · Cited by 574
Self-citationIncidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.117 · Cited by 507
Assembly of allosteric macromolecular switches: lessons from PKA
Taylor, S. S., Ilouz, R., Zhang, P., & Kornev, A. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3432 · Cited by 477
Research works printed but not linked: 1
- Bertherat J, 2003, Cancer Res, 63, 5308
Cited by
Items 201–300 of 475
Update on primary micronodular bilateral adrenocortical diseases
Maillet, M., Bourdeau, I., & Lacroix, A. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000538 · Cited by 18
A unified cause for adrenal Cushing's syndrome
Kirschner, L. S. (2014) · Science · doi:10.1126/science.1254901 · Cited by 17
Chen, S., Li, R., Lü, L., Duan, L., Zhang, X., Tong, A., Pan, H., Zhu, H., & Lu, Z. (2017) · Endocrine · doi:10.1007/s12020-017-1436-9 · Cited by 17
Stölting, G., Vo, K. N. T., Haus, J., & Scholl, U. I. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-01020-6 · Cited by 17
The Role of gsp Mutations on the Development of Adrenocortical Tumors and Adrenal Hyperplasia
Fragoso, M. C. B. V., Wanichi, I. Q., Cavalcante, I. P., & Mariani, B. M. P. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00104 · Cited by 17
Bilateral Adrenocortical Nodular Disease and Cushing's Syndrome
Bouys, L., Violon, F., Louiset, E., Sibony, M., Lefèbvre, H., & Bertherat, J. Y. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae419 · Cited by 17
Self-citationImproved and individualized approach to adrenal surgery
Carling, T., & LaRue, M. (2025) · Endocrine Related Cancer · doi:10.1530/erc-24-0296 · Cited by 17
Vassiliadi, D. A., Tzanela, M., Tsatlidis, V., Margelou, E., Tampourlou, M., Mazarakis, N., Piaditis, G. P., & Tsagarakis, S. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1653 · Cited by 16
Approach to the Patient With Bilateral Adrenal Masses
Vassiliadi, D. A., Delivanis, D. A., Papalou, O., & Tsagarakis, S. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae164 · Cited by 16
Seidel, E., & Scholl, U. I. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00075 · Cited by 16
Hyperplasia in glands with hormone excess
Marx, S. J. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0171 · Cited by 16
In Situ Metabolomics of Cortisol-Producing Adenomas
Murakami, M., Sun, N., Li, F., Feuchtinger, A., Gómez-Sánchez, C. E., Faßnacht, M., Reincke, M., Bancos, I., Walch, A. K., Kroiß, M., et al. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvac191 · Cited by 16
Self-citationWeigand, I., Ronchi, C. L., Vanselow, J. T., Bathon, K., Lenz, K., Herterich, S., Schlösser, A., Kroiß, M., Faßnacht, M., Calebiro, D., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd4176 · Cited by 16
Self-citationCharacterization of Adrenal miRNA-Based Dysregulations in Cushing’s Syndrome
Vetrivel, S., Zhang, R., Engel, M., Oßwald, A., Watts, D., Chen, A., Wielockx, B., Sbiera, S., Reincke, M., & Riester, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147676 · Cited by 16
Self-citationSoto-Rivera, C. L., & Majzoub, J. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00003-9 · Cited by 15
Disorders of the adrenal cortex: Genetic and molecular aspects
Pitsava, G., Maria, A. G., & Faucz, F. R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.931389 · Cited by 15
Self-citationThe Recovery of Hypothalamic-Pituitary-Adrenal Axis Is Rapid in Subclinical Cushing Syndrome
Kim, H. K., Yoon, J. H., Jeong, Y. A., & Kang, H. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.4.592 · Cited by 15
Wang, Y., Sato, M., Guo, Y. L., Bengtsson, T., & Nedergaard, J. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.07.029 · Cited by 15
Genetic Diagnosis through Whole-Exome Sequencing
van der Zwaag, P. A., Jongbloed, J. D. H., & van Tintelen, J. P. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1315908 · Cited by 15
A most versatile kinase: The catalytic subunit of PKA in T-cell biology
Postler, T. S. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.01.005 · Cited by 15
Cholesterol Biosynthesis and Trafficking in Cortisol-Producing Lesions of the Adrenal Cortex
London, E., Wassif, C. A., Horvath, A., Tatsi, C., Angelousi, A. G., Karageorgiadis, A. S., Porter, F. D., & Stratakis, C. A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2212 · Cited by 15
Self-citationMolecular Basis for Ser/Thr Specificity in PKA Signaling
Knape, M. J., Wallbott, M., Burghardt, N. C. G., Bertinetti, D., Hornung, J., Schmidt, S. H., Lorenz, R., & Herberg, F. W. (2020) · Cells · doi:10.3390/cells9061548 · Cited by 15
Baba, R., Oki, K., Gómez-Sánchez, C. E., Otagaki, Y., Itcho, K., Kobuke, K., Kodama, T., Nagano, G., Ohno, H., Yoneda, M., et al. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111456 · Cited by 14
Schalm, S. S., O’Hearn, E., Wilson, K., LaBranche, T. P., Silva, G., Zhang, Z., DiPietro, L., Bifulco, N., Woessner, R., Stransky, N., et al. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2022.11.004 · Cited by 14
Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation
Tetti, M., Gong, S., Veglio, F., Reincke, M., & Williams, T. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.934326 · Cited by 14
Self-citationWu, W.-C., Peng, K., Lu, J., Chan, C., Wang, C., Tseng, F., Yang, W., Lin, Y., Lin, P., Chen, T.-C., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0286 · Cited by 14
Discovery of a Cushing’s syndrome protein kinase A mutant that biases signaling through type I AKAPs
Omar, M. H., Byrne, D. P., Shrestha, S., Lakey, T. M., Lee, K., Lauer, S. M., Collins, K. B., Daly, L. A., Eyers, C. E., Baird, G. S., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl1258 · Cited by 14
Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas
Larkin, S. J., Ferraù, F., Karavitaki, N., Hernández-Ramírez, L. C., Ansorge, O., Grossman, A. B., & Korbonits, M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0545 · Cited by 14
In-vivo detection of binary PKA network interactions upon activation of endogenous GPCRs
Röck, R., Bachmann, V. A., Bhang, H.-E. C., Malleshaiah, M. K., Raffeiner, P., Mayrhofer, J. E., Tschaikner, P., Bister, K., Aanstad, P., Pomper, M. G., et al. (2015) · Scientific Reports · doi:10.1038/srep11133 · Cited by 13
Li, X., Wang, B., Tang, L., Lang, B., Zhang, Y., Zhang, F., Chen, L., Ouyang, J., & Zhang, X. (2016) · Clinical Endocrinology · doi:10.1111/cen.13134 · Cited by 13
Martinerie, L., Bouligand, J., North, M.-O., Bertherat, J. Y., Assié, G., & Espiard, S. (2024) · Annales d Endocrinologie · doi:10.1016/j.ando.2024.01.005 · Cited by 13
Self-citationPeverelli, E., Catalano, R., Giardino, E., Treppiedi, D., Morelli, V., Ronchi, C. L., Vaczlavik, A., Fusco, N., Ferrero, S., Bertherat, J. Y., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.025 · Cited by 13
Self-citationShimada, H., Yamazaki, Y., Sugawara, A., Sasano, H., & Nakamura, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9080892 · Cited by 13
Link between steroidogenesis, the cell cycle, and PKA in adrenocortical tumor cells
Rizk‐Rabin, M., Chaoui-Ibadioune, S., Vaczlavik, A., Ribes, C., Polak, M., Ragazzon, B., & Bertherat, J. Y. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110636 · Cited by 13
Self-citationcAMP/protein kinase A signalling pathway and adrenocortical adenomas
Ronchi, C. L. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.06.003 · Cited by 13
Self-citationThe Spectrum of GH Excess in Carney Complex and Genotype-phenotype Correlations
Tatsi, C., Pitsava, G., Faucz, F. R., Keil, M. F., & Stratakis, C. A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae253 · Cited by 13
Self-citationPituitary Gland: Pituitary Hormones
Emerald, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-384947-2.00548-1 · Cited by 12
Molecular genetics of Conn adenomas in the era of exome analysis
Zein, R. M. E., Boulkroun, S., Fernandes-Rosa, F. L., & Zennaro, M. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.07.006 · Cited by 12
65 YEARS OF THE DOUBLE HELIX: Endocrine tumour syndromes in children and adolescents
Goudie, C., Hannah‐Shmouni, F., Kavak, M., Stratakis, C. A., & Foulkes, W. D. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0160 · Cited by 12
Self-citationIkumawoyi, V. O., Lynch, K. D., Iverson, D. T., Call, M. R., Yue, G. E., Prasad, B., & Clarke, J. (2024) · Toxicon · doi:10.1016/j.toxicon.2024.108072 · Cited by 12
Papanastasiou, L., Fountoulakis, S., Voulgaris, N., Kounadi, T., Choreftaki, T., Kostopoulou, A., Zografos, G., Lyssikatos, C., Stratakis, C. A., & Piaditis, G. P. (2015) · HORMONES · doi:10.1007/bf03401413 · Cited by 12
Self-citationLipofuscin Accumulation in Cortisol-Producing Adenomas With and Without PRKACA Mutations
Angelousi, A. G., Szarek, E., Schram, V., Kebebew, E., Quezado, M., & Stratakis, C. A. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-116385 · Cited by 12
Self-citationYener, S., Seçil, M., Demir, Ö., Saydam, B. Ö., & Yörükoğlu, K. (2018) · Clinical Endocrinology · doi:10.1111/cen.13587 · Cited by 11
Saygılı, E. S., & Yıldız, B. O. (2021) · Endocrine · doi:10.1007/s12020-020-02567-z · Cited by 11
Olivieri, C., Walker, C., Veliparambil Subrahmanian, M., Porcelli, F., Taylor, S. S., Bernlohr, D. A., & Veglia, G. (2023) · FEBS Letters · doi:10.1002/1873-3468.14610 · Cited by 10
Humbert, A.-L., Lecoanet, G., Moog, S., Bouderraoui, F., Bresler, L., Vignaud, J.-M., Chevalier, E., Brunaud, L., Klein, M., & Cuny, T. (2018) · Endocrine · doi:10.1007/s12020-018-1522-7 · Cited by 10
Teuber, J. P., Nanba, K., Turcu, A. F., Chen, X., Zhao, L., Else, T., Auchus, R. J., Rainey, W. E., & Rege, J. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105924 · Cited by 10
Genetics improves understanding of adrenocortical tumours
BERTAGNA, X. Y. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.215 · Cited by 10
Phosphodiesterase 8B and cyclic AMP signaling in the adrenal cortex
Leal, L. F., Szarek, E., Faucz, F. R., & Stratakis, C. A. (2015) · Endocrine · doi:10.1007/s12020-015-0621-y · Cited by 10
Self-citationSu, H., Ma, D., Shang, H., Fan, J., & Zhu, H. (2020) · Gene · doi:10.1016/j.gene.2020.144791 · Cited by 10
Adrenal Cushing’s syndrome in pregnancy: Clinical and molecular characterisation of a case
Trinh, A., Chan, I., Alexiadis, M., Pell, M., Kumar, B., & Fuller, P. J. (2015) · Obstetric Medicine · doi:10.1177/1753495x15618542 · Cited by 10
Luzi, N. M., Lyons, C. E., Peterson, D. L., & Ellis, K. C. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12396 · Cited by 10
Wei, D.-L., Du, J., Li, H., Cao, G., & Wang, M. (2025) · Environment International · doi:10.1016/j.envint.2025.109947 · Cited by 10
Kersten, C. A., Sloey, E. N., Zhou, E., Peng, Y., Torbenson, M. S., & Guo, Y. (2017) · Liver Research · doi:10.1016/j.livres.2017.12.003 · Cited by 10
Newell-Price, J. D. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00017-9 · Cited by 9
Republished: Clinicopathological correlates of adrenal Cushing's syndrome
Duan, K., Hernandez, K., & Mete, Ö. (2015) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2014-202612rep · Cited by 9
Daniel, E., & Newell-Price, J. D. C. (2017) · Medicine · doi:10.1016/j.mpmed.2017.05.007 · Cited by 9
PRKACB is a novel imprinted gene in marsupials
Newman, T. A. C., Bond, D. M., Ishihara, T., Rizzoli, P., Gouil, Q. A., Hore, T. A., Shaw, G., & Renfree, M. B. (2024) · Epigenetics & Chromatin · doi:10.1186/s13072-024-00552-8 · Cited by 9
Spontaneous resolution of avascular necrosis of femoral heads following cure of Cushing’s syndrome
Pazderska, A., Crowther, S., Govender, P., Conlon, K. C., Sherlock, M., & Gibney, J. (2016) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-16-0015 · Cited by 9
Tatsi, C., Maria, A. G., Malloy, C., Lin, L., London, E., Settas, N., Flippo, C. L., Keil, M. F., Hannah‐Shmouni, F., Hoffman, D. A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab118 · Cited by 9
Self-citationMucignat‐Caretta, C., & Caretta, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093051 · Cited by 9
Road map for fibrolamellar carcinoma: progress and goals of a diversified approach
Kastenhuber, E. R., Craig, J., Ramsey, J. E., Sullivan, K. M., Sage, J., de Oliveira, S., Riehle, K. J., Scott, J. D., Gordan, J. D., Bardeesy, N. M., et al. (2019) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s194764 · Cited by 9
Carney complex review: Genetic features
Schamun, M. B. B., Correa, R., Graffigna, P., de Miguel, V., & Day, P. (2018) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2017.09.004 · Cited by 9
Zhou, W., Wu, L., Xie, J., Su, T., Jiang, L., Jiang, Y., Cao, Y., Liu, J., Ning, G., & Wang, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162606 · Cited by 8
Motomura, N., Yamazaki, Y., Koga, D., Harashima, S., Gao, X., Tezuka, Y., Omata, K., Ono, Y., Morimoto, R., Satoh, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042174 · Cited by 8
Allosteric pluripotency: challenges and opportunities
Akimoto, M., Pomier, K. M., VanSchouwen, B., Byun, J. A., Khamina, M., & Melacini, G. (2022) · Biochemical Journal · doi:10.1042/bcj20210528 · Cited by 8
Systematic Quantification of GPCR/cAMP-Controlled Protein Kinase A Interactions
Torres‐Quesada, O., Röck, R., & Stefan, E. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-110791 · Cited by 8
Therapeutic compounds for Cushing’s syndrome: a patent review (2012-2016)
Ma, L., Yin, L., & Hu, Q. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1217331 · Cited by 8
Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance
Leo, A. D., Ruscelli, M., Maloberti, T., Coluccelli, S., Repaci, A., de Biase, D., & Tallini, G. (2023) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-023-03713-4 · Cited by 8
Di Dalmazi, G., Timmers, H. J. L. M., Arnaldi, G., Küsters, B., Scarpelli, M., Bathon, K., Calebiro, D., Beuschlein, F., Hermus, A., & Reincke, M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02209 · Cited by 8
Self-citationKamilaris, C. D. C., & Stratakis, C. A. (2018) · HORMONES · doi:10.1007/s42000-018-0072-y · Cited by 7
Self-citationPinpointing a hotspot in adrenal Cushing syndrome
Giordano, T. J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.89 · Cited by 7
Cushing's Syndrome in Pregnancy Secondary to Adrenocortical Adenoma: A Case Series and Review
Wang, Y., An, Y., Hou, X., Xu, Y., Li, Z., Liu, X., Zheng, F., Sun, M., Han, R., Lü, C., et al. (2024) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.474 · Cited by 7
Mutational landscape of non-functional adrenocortical adenomas
Wu, L., Xie, J., Qi, Y., Su, T., Jiang, L., Zhou, W., Jiang, Y., Zhang, C., Zhong, X., Cao, Y., et al. (2022) · Endocrine Related Cancer · doi:10.1530/erc-21-0410 · Cited by 7
Animal Models of Adrenocortical Tumorigenesis
Galac, S., & Wilson, D. B. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.003 · Cited by 7
Molecular and Genetics Perspectives on Primary Adrenocortical Hyperfunction Disorders
Kim, S., Chaudhary, P. K., & Kim, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111341 · Cited by 7
Louiset, E., Duparc, C., & Lefèbvre, H. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.07.003 · Cited by 7
Targeting the Architecture of Deregulated Protein Complexes in Cancer
Stefan, E., Troppmair, J., & Bister, K. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.07.001 · Cited by 7
Clinical and molecular characterization of an infant with a tandem duplication and deletion of 19p13
Tan, R. N. G. B., Witlox, R. S. G. M., Hilhorst‐Hofstee, Y., Peeters‐Scholte, C. M. P. C. D., den Hollander, N. S., Ruivenkamp, C. A. L., Hoffer, M. J. V., Hansson, K. B. M., van Roosmalen, M. J., Kloosterman, W. P., et al. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37076 · Cited by 7
Lin, J., Li, Y., Huang, Z., Zhu, Y., Li, L., Yang, H., Liang, X., Qin, Y., Zhou, J., Xian, J., et al. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01645-x · Cited by 7
Yang, W.-R., Liang, X., Qin, Y., Yang, H., He, S.-Z., Huang, Z., Liu, Y., & Luo, Z. (2024) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2022-0491 · Cited by 7
Biochemical Analysis of AKAP-Anchored PKA Signaling Complexes
Byrne, D. P., Omar, M. H., Kennedy, E. J., Eyers, P. A., & Scott, J. D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2245-2_19 · Cited by 7
Blumenthal, D., Copps, J., Smith‐Nguyen, E. V., Zhang, P., Heller, W. T., & Taylor, S. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.584177 · Cited by 7
β-Catenin activation and illicit receptor expression in adrenocortical cells
Mestre, J. L., Thomas, M., Duparc, C., Val, P., Bures, C., Tuech, J., Sabourin, J., Baert‐Desurmont, S., Lefèbvre, H., & Louiset, E. (2021) · Endocrine Related Cancer · doi:10.1530/erc-21-0298 · Cited by 7
Nonga, O. E., Enkvist, E., Herberg, F. W., & Uri, A. (2020) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2020.1772038 · Cited by 7
Advances in the Diagnosis and Medical Management of Cushing's Syndrome
Delivanis, D. A., Sharma, A. R., Hamidi, O., Shah, M., & Bancos, I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-66195-9.00015-7 · Cited by 6
The molecular genetics of adrenal cushing
Vaduva, P., & Bertherat, J. Y. (2024) · HORMONES · doi:10.1007/s42000-024-00608-0 · Cited by 6
Self-citationAdrenal hyperplasias in childhood: An update
Pitsava, G., & Stratakis, C. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.937793 · Cited by 6
Self-citationGenetics of Cardiac Tumours: A Narrative Review
Al-Rasheed, M. M. (2023) · Heart Lung and Circulation · doi:10.1016/j.hlc.2023.11.005 · Cited by 6
Kirschner, L. S., & Stratakis, C. A. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0246-x · Cited by 6
Self-citationUncoupling of Secretion From Growth in Some Hormone Secretory Tissues
Marx, S. J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2113 · Cited by 6
Advances in understanding the molecular underpinnings of adrenocortical tumors
Nicolson, N. G., Man, J., & Carling, T. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000415 · Cited by 6
Bloyd, M., Settas, N., Faucz, F. R., Sinaii, N., Bathon, K., Iben, J., Coon, S. L., Caprio, S., Stratakis, C. A., & London, E. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab071 · Cited by 6
Self-citationGenetics of Pituitary Adenomas
Bogusławska, A., Gilis‐Januszewska, A., & Korbonits, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-90475-3_4 · Cited by 6
Mechanism of ectopic hormone receptors in adrenal tumors and hyperplasia
Kamenický, P., & Lacroix, A. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.08.012 · Cited by 6
Etiopathogeny of Primary Adrenal Hypercortisolism
Vélayoudom‐Céphise, F., Haissaguerre, M., & Tabarin, A. (2016) · Frontiers of hormone research · doi:10.1159/000443863 · Cited by 6
Recent progress in pathophysiology of cortisol-producing adrenal tumor
Yanase, T. (2026) · Endocrine Journal · doi:10.1507/endocrj.ej25-0207 · Cited by 6
Sakaguchi, C., Ashida, K., Kohashi, K., Ohe, K., Fujii, Y. R., Yano, S., Matsuda, Y., Sakamoto, S., Sakamoto, R., Oda, Y., et al. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0345-8 · Cited by 6
Vaduva, P., Violon, F., Chansavang, A., Hadjadj, D., Raverot, G., Espiard, S., Attia, A., Bouys, L., Thomeret, L., Kuhn, A. W., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf255 · Cited by 5
Self-citationLodish, M. B., Keil, M. F., & Stratakis, C. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_15 · Cited by 5
Self-citation
Metadata
- Authors
- Beuschlein, F., Fassnacht, M., Assié, G., Calebiro, D., Stratakis, C. A., Osswald, A., Ronchi, C. L., Wieland, T., Sbiera, S., Faucz, F. R., Schaak, K., Schmittfull, A., Schwarzmayr, T., Barreau, O., Vezzosi, D., Rizk-Rabin, M., Zabel, U., Szarek, E., Salpea, P., Forlino, A., Vetro, A., Zuffardi, O., Kisker, C., Diener, S., Meitinger, T., Lohse, M. J., Reincke, M., Bertherat, J., Strom, T. M., & Allolio, B.
- Affiliations
- University of Würzburg (DE)
- Centre National de la Recherche Scientifique (FR)
- National Institutes of Health (US)
- Helmholtz Munich (DE)
- University of Pavia (IT)
- Policlinico San Matteo Fondazione (IT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-03-13
- Volume
- 370
- Issue
- 11
- Pages
- 1019-1028
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4727447
- OpenAlex
- W2040816499
- Cited by
- 443
- References
- 40
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 28 · 2023: 26 · 2022: 39 · 2021: 40 · 2020: 28 · 2019: 25 · 2018: 34 · 2017: 38 · 2016: 51 · 2015: 50 · 2014: 38
- FWCI
- 58.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- George Washington University
- Johns Hopkins University
- Cedars-Sinai Medical Center
- Quest Diagnostics
- Otsuka America
- European Commission (259735)
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (ZIAHD008920)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- Cushing's syndrome, adrenal hyperplasia, PRKACA, protein kinase A catalytic subunit, somatic mutations, adrenocortical tumors, hypercortisolism
- MeSH terms
- Adenoma, Adrenal Gland Neoplasms, Adrenal Hyperplasia, Congenital, Adult, Cushing Syndrome, Humans, Hydrocortisone, Middle Aged, Mutation, Protein Conformation, Sequence Analysis, DNA, Cyclic AMP-Dependent Protein Kinases, Germ-Line Mutation, Catalytic Domain, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.